PFIZER INC Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
PFIZER INC (PFE) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent of -$365.00 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-27.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent · last filed 2020-02-27
- PFIZER INC other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2016-07-03 was $628.00M.
- PFIZER INC other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2016-04-03 was $2.00M.
- PFIZER INC other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2014-06-29 was $238.00M.
- PFIZER INC other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2014-03-30 was -$119.00M.
- PFIZER INC other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2019 was -$365.00M.
- PFIZER INC other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2018 was -$1.04B, a 160.70% decline from fiscal 2017.
- PFIZER INC other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2017 was $1.72B.
- PFIZER INC other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2016 was -$1.51B.
| Period end | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 9 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 month |
|---|---|---|---|---|
| 2019-12-31 | -$365.00M 10-K · filed 2020-02-27 | |||
| 2018-12-31 | -$1.04B 10-K · filed 2020-02-27 | |||
| 2017-12-31 | $1.72B 10-K · filed 2020-02-27 | |||
| 2016-12-31 | -$1.51B 10-K · filed 2019-02-28 | |||
| 2016-07-03 | $628.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | $630.00M 10-Q · filed 2016-08-11 | ||
| 2016-04-03 | $2.00M 10-Q · filed 2016-05-12 | |||
| 2015-12-31 | -$2.21B 10-K · filed 2018-02-22 | |||
| 2014-06-29 | $238.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $119.00M 10-Q · filed 2014-08-07 | ||
| 2014-03-30 | -$119.00M 10-Q · filed 2014-05-08 | |||
| 2013-09-29 | $82.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | -$228.00M derived: sum of 2 quarters · filed 2013-11-08 | -$430.00M 10-Q · filed 2013-11-08 | |
| 2013-06-30 | -$310.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | -$512.00M 10-Q · filed 2013-08-09 | ||
| 2013-03-31 | -$202.00M 10-Q · filed 2013-05-10 | |||
| 2012-09-30 | $355.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | -$1.52B 10-Q · filed 2012-11-09 | ||
| 2012-07-01 | -$1.88B 10-Q · filed 2012-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |